17 10月 2022 by admin in UncategorizedComments 科越医药宣布 KP104 用于治疗阵发性睡眠性血红蛋白尿症(PNH)的 II 期 临床试验申请 已获得中国国家药品监督管理局批准
03 10月 2022 by admin in UncategorizedComments 科越医药 KP104 治疗系统性红斑狼疮相关血栓性微血管病(SLE-TMA)的 II 期临床试 验申请获得美国 FDA 批准
16 9月 2022 by admin in UncategorizedComments Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
15 9月 2022 by admin in UncategorizedComments Syros and Tyme Technologies Announce Stockholder Approval of Merger
15 8月 2022 by admin in UncategorizedComments Adicet Reports Second Quarter 2022 Financial Results and Provides Business Updates
08 8月 2022 by admin in UncategorizedComments Design Therapeutics Highlights Upcoming Milestones and Reports Second Quarter 2022 Financial Results
